文献
J-GLOBAL ID:201802267497733581
整理番号:18A1690174
好酸球増加症候群に対する高用量メポリズマブ治療の長期臨床転帰【JST・京大機械翻訳】
Long-Term Clinical Outcomes of High-Dose Mepolizumab Treatment for Hypereosinophilic Syndrome
著者 (10件):
Kuang Fei Li
(Human Eosinophil Section, LPD, NIAID, NIH, Bethesda, Md)
,
Fay Michael P.
(Biostatistics Research Branch, DCR, NIAID, NIH, Bethesda, Md)
,
Ware JeanAnne
(Human Eosinophil Section, LPD, NIAID, NIH, Bethesda, Md)
,
Wetzler Lauren
(Human Eosinophil Section, LPD, NIAID, NIH, Bethesda, Md)
,
Holland-Thomas Nicole
(Clinical Research Directorate/Clinical Monitoring Research Program, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Md)
,
Brown Thomas
(Human Eosinophil Section, LPD, NIAID, NIH, Bethesda, Md)
,
Ortega Hector
(Respiratory, US Medical Affairs, GlaxoSmithKline, La Jolla, Calif)
,
Steinfeld Jonathan
(Respiratory Therapy Area Unit and Flexible Discovery Unit, GlaxoSmithKline, Philadelphia, Pa)
,
Khoury Paneez
(Human Eosinophil Section, LPD, NIAID, NIH, Bethesda, Md)
,
Klion Amy D.
(Human Eosinophil Section, LPD, NIAID, NIH, Bethesda, Md)
資料名:
Journal of Allergy and Clinical Immunology: In Practice
(Journal of Allergy and Clinical Immunology: In Practice)
巻:
6
号:
5
ページ:
1518-1527.e5
発行年:
2018年
JST資料番号:
W3140A
ISSN:
2213-2198
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)